Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment (vol 4, 24, 2018)

被引：0
|
作者：
不详
机构：
来源：
CELL DEATH DISCOVERY | 2019年 / 5卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gefitinib for Non-Small Cell Lung Cancer Patients with Liver Cirrhosis
    Kim, Young Hak
    Mio, Tadashi
    Mishima, Michiaki
    INTERNAL MEDICINE, 2009, 48 (18) : 1677 - 1679
  • [32] Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3
    Shou, Jiawei
    You, Liangkun
    Yao, Junlin
    Xie, Jiansheng
    Jing, Jing
    Jing, Zhao
    Jiang, Liming
    Sui, Xinbing
    Pan, Hongming
    Han, Weidong
    CANCER LETTERS, 2016, 379 (01) : 124 - 133
  • [33] Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib
    HUANG YishengHUANG Biao and WU Yilong Guangdong Lung Cancer Institute Department of RadiologyGuangdong General Hospital and Guangdong Academy of Medical SciencesGuangzhou Guangdong China
    中华医学杂志（英文版）, 2011, (22) : 3834 - 3837
  • [34] Treatment after the Failure of Gefitinib in Patients with Advanced or Recurrent Non-small Cell Lung Cancer
    Maruyama, Riichiroh
    Wataya, Hiroshi
    Seto, Takashi
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2009, 29 (10) : 4217 - 4221
  • [35] Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib
    Huang Yi-sheng
    Huang Biao
    Wu Yi-long
    CHINESE MEDICAL JOURNAL, 2011, 124 (22) : 3834 - 3837
  • [36] Gefitinib treatment affects androgen levels in non-small cell lung cancer patients.
    Nishio, M
    Ohyanagi, F
    Horiike, A
    Satoh, Y
    Okumura, S
    Nakagawa, K
    Horai, T
    Ishikawa, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 692S - 692S
  • [37] SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
    M. Majem
    O. Juan
    A. Insa
    N. Reguart
    J. M. Trigo
    E. Carcereny
    R. García-Campelo
    Y. García
    M. Guirado
    M. Provencio
    Clinical and Translational Oncology, 2019, 21 : 3 - 17
  • [38] SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
    Majem, M.
    Juan, O.
    Insa, A.
    Reguart, N.
    Trigo, J. M.
    Carcereny, E.
    Garcia-Campelo, R.
    Garcia, Y.
    Guirado, M.
    Provencio, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (01): : 3 - 17
  • [39] Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer
    Cappuzzo, Federico
    Morabito, Alessandro
    Normanno, Nicola
    Bidoli, Paolo
    Del Conte, Alessandro
    Giannetta, Laura
    Montanino, Agnese
    Mazzoni, Francesca
    Buosi, Roberta
    Burgio, Marco Angelo
    Cerea, Giulio
    Chiari, Rita
    Cortinovis, Diego
    Finocchiaro, Giovanna
    Foltran, Luisa
    Migliorino, Maria Rita
    Tiseo, Marcello
    Ferrari, Silvia
    De Marinis, Filippo
    LUNG CANCER, 2016, 99 : 31 - 37
  • [40] Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
    Huang, Xiaoming
    Sun, Jingchun
    Sun, Jianli
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021, 22 (03) : 389 - 399
12345